Find comprehensive information on Adrenal Tumor, also known as Adrenal Neoplasm or Adrenal Mass. This resource offers guidance on clinical documentation, medical coding, and healthcare best practices related to Adrenal Tumor diagnosis. Learn about symptoms, diagnostic criteria, and treatment options for Adrenal Tumors to improve patient care and ensure accurate medical records. Explore relevant medical coding terminology for proper billing and documentation of this adrenal gland condition.
Abnormal growth in the adrenal gland, can be benign or cancerous.
Often asymptomatic. May cause high blood pressure, fatigue, weight changes, or hormonal imbalances.
Detected incidentally on imaging or during evaluation for hormonal issues. Treated in endocrinology or surgical settings.
Complete code families applicable to D35.00
| Description | When to use |
|---|---|
| Abnormal growth in the adrenal gland. | Use for any neoplastic growth, including benign and malignant tumors. Consider laterality. |
| Benign adrenal tumor, often non-functional. | Use for non-cancerous adrenal growths like adenomas. Specify hormone production if known. |
| Rare cancerous adrenal gland tumor. | Use for malignant adrenal tumors like adrenocortical carcinoma. Include staging if available. |
Missing laterality (left, right, bilateral) can impact coding accuracy and reimbursement for adrenal tumor procedures.
Incomplete documentation specifying benign or malignant nature affects proper ICD-10-CM code assignment (e.g., D35.0 vs. C74).
Unclear documentation of functional status (e.g., hormone-secreting) impacts code selection and potential clinical pathway variations.
Review imaging: location, size, features (ICD-10 C74.0-C74.9)
Biochemical evaluation: hormonal hypersecretion? (SNOMED CT 362235007)
Assess for symptoms: hypertension, weight gain? Document thoroughly.
Consider biopsy vs. observation: discuss risks/benefits with patient.
Patient presents with signs and symptoms suggestive of an adrenal tumor, also referred to as an adrenal neoplasm or adrenal mass. Clinical presentation includes [specific patient symptoms e.g., abdominal pain, flank pain, hypertension, weight gain, fatigue, muscle weakness, hirsutism, menstrual irregularities]. Differential diagnosis includes adrenal adenoma, adrenal carcinoma, pheochromocytoma, adrenocortical carcinoma, and other adrenal gland disorders. Physical examination revealed [specific findings e.g., palpable abdominal mass, elevated blood pressure]. Initial laboratory workup includes a comprehensive metabolic panel, complete blood count, and hormonal assays including cortisol, aldosterone, and catecholamines. Imaging studies, such as abdominal CT scan with contrast or adrenal MRI, are ordered to evaluate the size, location, and characteristics of the adrenal lesion. Further evaluation may include adrenal vein sampling to assess for hormone hypersecretion. Diagnosis of adrenal tumor is based on clinical findings, laboratory results, and imaging characteristics. Treatment options for adrenal tumors depend on the size, type, and functional status of the tumor and may include surgical resection (adrenalectomy), medical management for hormonal imbalances, or observation with serial imaging. Patient education regarding adrenal tumor symptoms, diagnosis, treatment options, and potential complications is provided. Follow-up appointments are scheduled for monitoring and ongoing management of the adrenal tumor. ICD-10 codes for adrenal tumor include [relevant ICD-10 codes e.g., D35.0, C74.1, D44.1]. CPT codes for related procedures include [relevant CPT codes e.g., for adrenalectomy, imaging studies, biopsies, etc.].
Differentiating benign from malignant adrenal incidentalomas (adrenal neoplasms or adrenal masses) in patients without a history of malignancy requires a multi-faceted approach. Key imaging features on CT include size, attenuation (Hounsfield Units), and enhancement washout characteristics. Incidentalomas greater than 4cm warrant further investigation. A non-contrast HU of <10 is highly suggestive of a benign adrenal adenoma. Rapid washout of contrast (>60% at 10 minutes post-contrast) also favors benignity. Hormonal evaluation is crucial. Measurement of serum metanephrines, normetanephrines, aldosterone, and renin activity can identify hormonally active tumors like pheochromocytomas or Conn's syndrome, which, while rare, can mimic malignancy. Consider implementing a dedicated adrenal protocol CT scan for precise characterization. If imaging and hormonal workup are inconclusive, biopsy may be considered, though it carries the risk of complications. Explore how S10.AI can help streamline the evaluation process for adrenal incidentalomas. Learn more about the role of advanced imaging techniques in adrenal tumor assessment.
Current guidelines for managing small (<4cm), non-functioning adrenal adenomas (also known as adrenal neoplasms or adrenal masses) discovered incidentally generally favor a conservative approach. For asymptomatic patients, repeat imaging with a dedicated adrenal protocol CT at 6-12 months and hormonal evaluation with serum metanephrines and normetanephrines are often recommended to assess for growth and exclude subclinical pheochromocytoma. If the adenoma remains stable in size and hormonally inactive, further follow-up may be individualized based on patient risk factors. It is essential to consider the patient's overall health status and comorbidities when determining the appropriate frequency of follow-up. Explore how S10.AI can assist in implementing guideline-concordant management of adrenal incidentalomas. Consider implementing standardized reporting templates to improve the consistency of adrenal incidentaloma management within your practice.
Adrenalectomy, whether open or laparoscopic, is indicated for adrenal masses suspected or confirmed to be malignant, hormonally active tumors causing significant clinical manifestations (e.g., Cushing's syndrome, Conn's syndrome, pheochromocytoma), or large (>4-6cm) indeterminate masses. Preoperative considerations include thorough hormonal and imaging evaluation to characterize the tumor and assess its functionality. For pheochromocytomas, appropriate alpha and beta-blockade is critical to prevent intraoperative hypertensive crises. Careful assessment of the patient's overall health and surgical risk is essential. Explore how S10.AI can support surgical planning and enhance pre-operative risk stratification. Learn more about minimizing post-operative complications and optimizing recovery after adrenalectomy.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.